Cooke & Bieler’s CONMED CNMD Stock Holding History

Cooke & Bieler’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.8M	Sell	573,498 -414,285	-42%	-$14.9M	0.22%	84
2026 Q1	$34.9M	Buy	987,783 +119,966	+14%	+$4.88M	0.4%	80
2025 Q4	$35.2M	Buy	867,817 +163,494	+23%	+$7.11M	0.37%	78
2025 Q3	$33.1M	Buy	704,323 +5,250	+0.8%	+$272K	0.34%	82
2025 Q2	$36.4M	Sell	699,073 -3,550	-0.5%	-$195K	0.36%	83
2025 Q1	$42.4M	Buy	702,623 +38,580	+6%	+$2.49M	0.42%	75
2024 Q4	$45.4M	Sell	664,043 -4,760	-0.7%	-$332K	0.44%	74
2024 Q3	$48.1M	Buy	668,803 +40,182	+6%	+$2.84M	0.44%	76
2024 Q2	$43.6M	Buy	628,621 +209,064	+50%	+$15.3M	0.42%	78
2024 Q1	$33.6M	Buy	+419,557	New	+$37.4M	0.31%	85

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Cooke & Bieler's CNMD Position: Q2 2026 in Review

Cooke & Bieler reduced its CONMED (CNMD) stake by 42% in Q2 2026, selling an estimated $14.9M and leaving 573,498 shares worth $18.8M. The position accounts for 0.22% of the portfolio, ranked #84.

Cooke & Bieler first reported a position in CNMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $48.1M in Q3 2024. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Cooke & Bieler held 573,498 shares of CONMED worth $18.8M as of Q2 2026.
Cooke & Bieler sold 414,285 CONMED shares in Q2 2026, an estimated $14.9M.
CONMED made up 0.22% of Cooke & Bieler's portfolio in Q2 2026, its #84 holding.
Cooke & Bieler first reported a position in CONMED in Q1 2024 and has held it in 10 quarters since.
Cooke & Bieler's CONMED position peaked at $48.1M in Q3 2024.
246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Cooke & Bieler's 13F filing for Q2 2026, filed 30 Jul 2026.